|
|||||
|
|
Long‐term efficacy and safety results from an open‐label phase III study (UNCOVER‐J) in Japanese plaque psoriasis patients: impact of treatment withdrawal and retreatment of ixekizumab |
|
| Authors: | Y. Umezawa H. Torisu‐Itakura Y. Morisaki H. ElMaraghy K. Nakajo N. Akashi H. Saeki |
| Abstract: | |
| Keywords: | |